M S Simberkoff
Overview
Explore the profile of M S Simberkoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oxman M, Levin M, Johnson G, Schmader K, Straus S, Gelb L, et al.
N Engl J Med
. 2005 Jun;
352(22):2271-84.
PMID: 15930418
Background: The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus (VZV). We tested the...
2.
Rabeneck L, Menke T, Simberkoff M, Hartigan P, Dickinson G, Jensen P, et al.
J Clin Epidemiol
. 2001 Dec;
54(12):1195-203.
PMID: 11750188
Disease-specific registries have many important applications in epidemiologic, clinical and health services research. Since 1989 the Department of Veterans Affairs has maintained a national HIV registry. VA's HIV registry is...
3.
Menke T, Rabeneck L, Hartigan P, Simberkoff M, Wray N
Inquiry
. 2000 Jul;
37(1):61-74.
PMID: 10892358
This study estimates the impact of clinical and socioeconomic characteristics on health care use for HIV-infected patients. Data come from the Department of Veterans Affairs (VA) HIV Registry, which electronically...
4.
Laal S, Samanich K, Sonnenberg M, Belisle J, OLeary J, Simberkoff M, et al.
J Infect Dis
. 1997 Jul;
176(1):133-43.
PMID: 9207359
Antibodies to purified, size-fractionated secreted proteins of Mycobacterium tuberculosis in sera from patients with human immunodeficiency virus (HIV) infection and active tuberculosis (HIV/TB patients), and in stored sera obtained from...
5.
OBRIEN W, Hartigan P, Daar E, Simberkoff M, Hamilton J
Ann Intern Med
. 1997 Jun;
126(12):939-45.
PMID: 9182470
Background: Markers are needed for assessing response to antiretroviral therapy over time. The CD4+ lymphocyte count is one such surrogate, but it is relatively weak. Objective: To assess the association...
6.
Kovacs A, Leaf H, Simberkoff M
Med Clin North Am
. 1997 Mar;
81(2):319-43.
PMID: 9093231
Non-opportunistic bacterial infections are an important cause of morbidity and mortality for HIV-infected adults and children. Factors associated with increased risk of these include altered B- and T-cell function; altered...
7.
Simberkoff M, Santos M
Curr Opin Pulm Med
. 1996 May;
2(3):228-35.
PMID: 9363144
Pneumonia is an important cause of morbidity and mortality in the United States. The provision of effective prophylaxis for pneumonia has become a major goal for both public health officials...
8.
OBRIEN W, Hartigan P, Martin D, Esinhart J, Hill A, Benoit S, et al.
N Engl J Med
. 1996 Feb;
334(7):426-31.
PMID: 8552144
Background: Clinical trials of antiretroviral drugs can take years to complete because the outcomes measured are progression to the acquired immunodeficiency syndrome (AIDS) or death. Trials could be accelerated by...
9.
Sharkey P, Graybill J, Johnson E, Hausrath S, Pollard R, Kolokathis A, et al.
Clin Infect Dis
. 1996 Feb;
22(2):315-21.
PMID: 8838189
The study objective was to obtain preliminary information regarding the safety and efficacy of amphotericin B (AmB) lipid complex (ABLC) in the treatment of AIDS-associated cryptococcal meningitis. Of 55 patients...
10.
Simberkoff M, Hartigan P, Hamilton J, DAY P, Diamond G, Dickinson G, et al.
J Acquir Immune Defic Syndr Hum Retrovirol
. 1996 Feb;
11(2):142-50.
PMID: 8556396
Following a 4-year controlled trial comparing early and later zidovudine treatment, we conducted an additional 3-year follow-up. Of the original 338 patients, 275 participated. Clinical outcome measures were AIDS and...